Axio Biosolutions Private Limited

About Axio Biosolutions Private Limited

Axiobio operates in the healthcare sector, specializing in advanced wound care solutions and infection control products. The company serves a diverse range of clients, including hospitals, clinics, and the Indian armed forces. Axiobio's core offerings include non-woven microfibre dressings, bioactive microfiber gelling technology, and haemostatic dressings that control bleeding within minutes. Additionally, the company provides alcohol-based hand sanitizers and surgical hand disinfectants, crucial for maintaining hygiene standards, especially during the Covid-19 pandemic.

The market Axiobio operates in is highly competitive, focusing on wound care and infection control, which are critical areas in healthcare. The business model revolves around the development, manufacturing, and distribution of its specialized products. Revenue is generated through direct sales to healthcare institutions and partnerships with institutional stockists and hospital stores.

Axiobio's innovative technologies, such as Protonated Bioadhesive Technology (PBT) and Bioactive Microfiber Gelling Technology (BMG), set it apart from competitors by offering superior performance in wound healing and infection prevention. The company's products are particularly effective for patients on blood thinners and those with chronic wounds, such as diabetic ulcers.